Orforglipron (LY3502970), a novel, oral nonpeptide glucagonlike peptide1 receptor agonist: A Phase 1a, blinded, placebocontrolled, randomized, singleand multipleascendingdose study in healthy participants
Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study
The Importance of Medical Supervision for Microdosing GLP-1 medications work even in tiny doses
I think it's important to really understand that the people who are saying, "This medication is amazing and it changed my life," there's a self-selection bias here
(Ard, 2021) GLP-1 medications also slow the release of food from the stomach, which increases feelings of fullness after eating